BIO calls for approval of biotech salmon

05/1/2013 | BiofuelsDigest.com

BIO encouraged the FDA to approve AquaBounty Technologies' AquAdvantage biotech salmon, saying that all scientific steps required for regulatory approval have been completed. "This evaluation has been thorough. It is past time to provide a decision and let the market determine whether it supports this innovation that produces healthy food in a sustainable manner by using inland farms to help us meet global protein needs," said David Edwards, BIO's director of animal biotechnology.

View Full Article in:

BiofuelsDigest.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
MGR CLINICAL RESEARCH - 14000003MB
Abbott
Santa Clara, CA
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR